Peripheral Blood Stem Cell Autografts(PBSCT) for the Treatment of Childhood T-Cell Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma with Mediastinal Mass.
スポンサーリンク
概要
- 論文の詳細を見る
Seven children (3-17 y; median, 10 y), who had acute lymphoblastic leukemia (ALL) or non-Hodgkin's lymphoma (NHL) associated with mediastinal mass, underwent high-dose chemotherapy (MCVAC therapy) and peripheral blood stem cell autografts (PBSCT). None received total body irradiation. Four patients had ALL and three had NHL. In all patients, cancer cells had T cell surface makers. Five patients, including one with initial induction failure ALL, underwent PBSCT in the first complete remission (CR) and two patients did in the second CR. One patient received mediastinal irradiation before PBSCT. After PBSCT, hematopoietic recovery speed was fast and five of the seven patients have survived without relapse for 11-58 months. One patient, who had underwent initial PBSCT in the 1st CR and developed relapse, underwent the second PBSCT and still has remained in unmaintained CR for 18 months post-PBSCT. The data suggest that high-dose chemotherapy and PBSCT will become an effective therapeutic option for this particular group of patients.
- 特定非営利活動法人 日本小児血液・がん学会の論文
特定非営利活動法人 日本小児血液・がん学会 | 論文
- The Parent's Emotional Adaptation to the Children's Malignant Disease
- Side Effect of Cranial Radiation in Childhood Acute Leukemia
- Red Blood Cell Volume Distribution Width in Normal Children and in the Patients with Various Kinds of Hematological Disorders.
- Effective Conditioning of Donors for Granulocyte Transfusions with Recombinant Human Granulocyte Colony-Stimulating Factor.
- Two Infant Girls of CNS Leukemia with Chronic Subdural Hematoma